In vitro antimicrobial susceptibility of Porphyromonas gingivalis to azithromycin, a novel macrolide.
The in vitro antimicrobial susceptibility of Porphyromonas gingivalis to azithromycin, a new macrolide antibiotic of a new class known as azalides, was investigated by the agar dilution method on Brucella agar. Eighty-two P. gingivalis strains, 79 recent oral isolates, 1 nonoral isolate and 2 reference strains were included in the study. Azithromycin was highly effective against P. gingivalis. All strains were inhibited at 1.0 microgram/ml of azithromycin or less. The minimal inhibitory concentrations were 0.25 microgram/ml for 50% and 0.5 microgram/ml for 90%. These in vitro data as well as the favorable pharmacokinetics of azithromycin indicate that this new oral macrolide might be a good candidate for future clinical trials aiming to eradicate P. gingivalis from refractory periodontitis.
Pajukanta
R
R
Department of Periodontology, University of Helsinki, Finland.
D017963:Azithromycin / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests; D016966:Porphyromonas gingivalis / Q000187:drug effects*
D017963:Azithromycin